Ovarian Carcinoma Histotypes: Their Emergence as Important Prognostic and Predictive Markers
February 15th 2016The movement of ovarian carcinoma histotypes from ill-defined and poorly reproducible clusters of cases to distinct disease entities clearly has beneficial implications for patient management.
Metastatic HER2-Positive Breast Cancer: Tailoring Treatment Un-‘TIL’ We Get It Right...
February 15th 2016While we continue to be thankful for incremental gains in the treatment of our patients with metastatic HER2-positive breast cancer, much work remains in order to optimize and individualize care.